Stefania Vittoria Luisa Nicoletti Selected Research

Immunotherapy

5/2013

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefania Vittoria Luisa Nicoletti Research Topics

Disease

3	Melanoma (Melanoma, Malignant) 05/2013 - 12/2011
2	Neoplasms (Cancer) 05/2013 - 12/2011

Drug/Important Bio-Agent (IBA)

2	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 05/2013 - 12/2011
1	Temozolomide (Temodar)FDA LinkGeneric 05/2013
1	IpilimumabIBA 06/2012
1	VaccinesIBA 12/2011
1	Interleukin-2 (IL2)IBA 12/2011

Therapy/Procedure

1	Immunotherapy 05/2013
1	Withholding Treatment 06/2012
1	Drug Therapy (Chemotherapy) 06/2012
1	Therapeutics 06/2012